4574.T
TAIKO PHARMACEUTICAL CO.,LTD.
プライム · 医薬品 · 医薬品 · JP
JPY 254.00
−1.17%Aug 25, 2026, 08:56 UTC
Daiko Pharmaceutical announced on August 25 that it will apply to change its market segment from the Tokyo Stock Exchange Prime Market to the Standard Market, because its free-float market capitalization fell below the Prime maintenance standard.
Aug 13, 2026, 11:00 UTC
Taiko Pharmaceutical reported a 2.1-fold increase in recurring profit for the first half and a 15-fold increase for the April-June quarter.
Source: